LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,942 | -98.1% | 282 | -98.0% | 0.00% | -97.0% |
| Q2 2023 | $979,328 | +1920151.0% | 14,187 | +1248.6% | 0.03% | +1550.0% |
| Q1 2023 | $51 | -25.0% | 1,052 | -22.6% | 0.00% | -33.3% |
| Q4 2022 | $68 | -100.0% | 1,360 | -66.9% | 0.00% | 0.0% |
| Q3 2022 | $167,000 | -52.8% | 4,106 | -36.3% | 0.00% | -62.5% |
| Q2 2022 | $354,000 | +653.2% | 6,442 | +402.5% | 0.01% | – |
| Q1 2022 | $47,000 | +30.6% | 1,282 | +63.9% | 0.00% | -100.0% |
| Q4 2021 | $36,000 | +140.0% | 782 | +167.8% | 0.00% | – |
| Q3 2021 | $15,000 | -28.6% | 292 | -44.0% | 0.00% | -100.0% |
| Q2 2021 | $21,000 | -48.8% | 521 | -63.0% | 0.00% | 0.0% |
| Q1 2021 | $41,000 | -78.2% | 1,407 | -79.0% | 0.00% | -83.3% |
| Q4 2020 | $188,000 | +9300.0% | 6,699 | +9470.0% | 0.01% | – |
| Q3 2020 | $2,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |